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It is widely held that injured neurons in the central nervous system do not have the 
capacity to undergo axonal regeneration. Recently, however, there is mounting evidence 
that serotonin fibers are an exception to this rule. Serotonin fibers undergo long-distance 
regeneration in the neocortex after amphetamine lesion. They can also traverse the rift 
created by a penetrating injury in the neocortex. These new fibers are indistinguishable in 
morphology from spared axons and have been shown to be competent to release 
serotonin. While experimentally useful, these models do not mimic the most typical 
clinical injuries. Traumatic brain injury (TBI) is prevalent and can lead to pathologies such 
as depression that are a result of serotoninergic dysfunction. So whether serotonin fibers 
can regrow after TBI is an important question. To address this, we used a controlled 
cortical impact (CCI) model to evoke injury in adult mouse neocortex and assessed 
serotonin fiber innervation one week, one month, and three months after injury with 
immunohistochemistry. In the neocortex serotonin fibers traverse in an anterior to 
posterior direction. CCI, as well as an open skull injury without impact, resulted in 
decreases in serotonin fiber innervation posterior to the injury site one week after surgery. 
At one month and three months after surgery there was a significant regrowth of 
serotonin fibers posterior to the injury. We also quantified reactive astrocytes following 
TBI using GFAP immunohistochemistry. There was profound reactive astrogliosis one 
week after surgery that decreased close to control levels by three months. Interestingly, 
the amount of reactive gliosis was not correlated to the amount of serotonin fiber loss in 
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either regions anterior or posterior to the injury. Microglial density was not affected by 
TBI. In addition, we investigated whether a repetitive mild TBI model leads to serotonin 
fiber loss in mouse neocortex. We did not detect serotonin fiber loss across a range of 
injury severities despite the presence of reactive gliosis in the optic fiber tract 
accompanying these injuries. These findings indicate that serotonin fibers can be damaged 
in certain clinically relevant TBI models and are capable of regrowth following injury. 
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Chapter 1: Background 
 
Serotonin is a monoamine neurotransmitter with biological roles ranging from 
early development through the lifespan (Muller and Jacobs, 2010). Diverse receptors for 
serotonin are ubiquitous in the adult mammalian brain, explaining how serotonin can be 
involved in behaviors including, but not limited to, thermal regulation, feeding, sexual 
behavior, aggression, stress, response to pain, and mood (Lucki, 1998). Serotonin is 
synthesized in two steps from its precursor tryptophan, and is released both at synaptic 
contacts and via paracrine or volume transmission. In the cortex, volume transmission 
vastly dominates over synaptic transmission. Electron microscopy studies have revealed 
that the majority of bouton structures on serotonin fibers do not make post-synaptic 
contacts either on the dendrites or somata of neocortical neurons across a range of species 
(Beaudet and Descarries, 1978; DeFelipe and Jones, 1988; Horung, 2003). Concentration of 
serotonin in the milieu is in large part regulated by reuptake by the serotonin transporter 
SERT (Murphy and Lesch, 2008).  
 
There are seven families of serotonin receptors, named 5-HT1-7. With the exception of 5-
HT3, which is a ligand gated cation channel, serotonin receptors are G-protein coupled 
(Murphy et al., 1998). The subtypes of the largest receptor family, 5-HT1, are linked to Gi/o 
and inhibit cyclic adenosine monophosphate (cAMP) production leading to inhibitory 
effects. Subtypes of the 5-HT5 family also appear to couple to Gi/o (Nelson, 2004). Receptors 
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5-HT4, 5-HT6, and 5-HT7, are primarily coupled to Gs effector proteins, increase cAMP 
production, and are generally excitatory. The 5-HT2 family effector molecules are the Gq/11 
subunit, which activate phospholipase C. While evidence suggests that these receptor 
families have overlapping and diverse physiological roles, behavioral and 
pharmacological data suggest that 5-HT1A, 5-HT1B, and 5-HT2A receptors play the largest 
role in clinically relevant mood disorders (Fakhoury, 2016). 
 
Serotonin system in mice 
Nearly every structure in the brain receives serotonin fiber innervation. The serotonergic 
system in mice is divided into two distinct groups of neurons in the midbrain. The rostral 
group contains cell bodies that send projections to the forebrain while the caudal group 
of cell bodies sends projections to hindbrain and spinal cord (Figure 1; Tork, 1990). The 
caudal group includes the raphe magnus nucleus, raphe pallidus nucleus, and raphe 
obscurus, which all project to the spinal cord as well as the medullary reticular formation 
nuclei which have axonal projections that innervate the cerebellum (Manto et al., 2013).  
 
The rostral division contains the dorsal raphe nucleus and median raphe nucleus. Both of 
these nuclei have extensive ascending axons that follow a C-shaped projection through 
the lateral hypothalamus and basal forebrain in a dense path termed the medial forebrain 
bundle. The fibers then turn dorsally at the frontal cortex before turning posteriorly to 
continue through the parietal, occipital, and temporal cortex. Along the way axons branch 
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to innervate many forebrain structures including the hypothalamus, thalamus, amygdala, 
accumbens, striatum, and the olfactory bulbs. In the neocortex, fibers originating from the 
median raphe preferentially innervate layer 1 while fibers from the dorsal raphe 
preferentially innervate deeper layers (Vitalis et al., 2013). Along with different 
innervation patterns, the fibers from the median and dorsal raphe nuclei differ 
morphologically. Axons originating in the dorsal raphe are thin, branch profusely, and 
have small boutons. These fibers are not likely to form synaptic contacts. In contrast, fibers 
from the median raphe have large round boutons that have been shown with electron 
microscopy to form synaptic contacts on cell bodies and dendrites of their postsynaptic 
targets (Tork, 1990; Wilson and Molliver, 1994). 
 
 
Figure 1. Serotonin fiber innervation of the adult mouse brain. Serotonin cell bodies are 
located in brainstem nuclei and their axons project throughout the central nervous system 
innervating regions including the neocortex, nucleus accumbens (ac), amygdala (amg), 
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cerebellum (cer), hypothalamus (hyp), olfactory bulb (ob), striatum (str), and thalamus 
(th). DR = dorsal raphe, MnR = median raphe, MrN = medullary reticular nuclei, RMg = 
raphe magnus, ROb = raphe obscurus, RPa = raphe pallidus. 
 
 
Regenerative capacity of serotonin fibers 
It is widely held that injured neurons in the central nervous system do not have the 
capacity to regenerate axons (Tuszynski and Steward, 2012). While there have been 
reports of rewiring in the neocortex following laser ablation of axons from excitatory, 
glutamatergic neurons, regrowth is rare (Canty et al., 2013). Regrowth into or through an 
injured area can take one of two distinct forms, which are not mutually exclusive. 
Regrowth from a transected or injured axon itself, whether directly from the severed end 
or proximal to it, is considered regeneration. Meanwhile, growth from non-damaged 
axons to compensate for innervation loss from damaged axons is termed local sprouting 
rather than regeneration (Tuszynski and Steward, 2012).  
 
One reason that regrowth is rare following injury rests on the fact that damaged tissue is 
not a permissive environment for axonal growth. Myelin debris within the damaged 
region expresses several inhibitory molecules including Nogo-A.  The Nogo-66 domain 
of Nogo-A acts on the Nogo-A receptor NgR to cause axonal growth cone collapse 
(Fournier et al., 2001). Extracellular matrix molecules secreted by support cells responding 
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to the injury can also inhibit growth in the damaged area.  Reactive astrocytes have been 
shown to secrete chondroitin sulfate proteogylcans (CSPGs) which contain linear 
disaccharide chains that act as a stop signals and serve to hinder axonal growth (Bovolenta 
et al., 1993). In addition to these stop signals, chemorepellent molecules such as Slit are 
also expressed at the injury site preventing growth of axons into the area (Hagino et al., 
2003). 
 
Limited rewiring due to local sprouting or regeneration from damaged ends is suggestive 
of the fact that neurons can retain some intrinsic capacity to regrow axons. Not all cell 
types appear to have the capacity to rewire locally, however, even in a permissive 
environment. Indeed, recent studies are beginning to converge on the conclusion that 
diminished intrinsic regenerative capacity in mature neurons is a major factor limiting 
regeneration (Sun and He, 2010). Intrinsic regenerative capacity is likely to have many 
determinants. These include, but may not be limited to, expression of receptors for stop 
signals, retrograde transport of injury signals to the nucleus from the site of axonal injury, 
and the transcriptional and translational machinery necessary to induce a growth 
program (Zou et al., 2009). 
 
There is mounting evidence that serotonin neurons have an unusually potent intrinsic 
capacity for axonal regeneration. Following cervical spine injury serotonin fibers were 
found to regenerate into a peripheral nerve graft that was treated with chondroitinase 
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ABC (ChABC) to break down the inhibitory disaccharide chains on CSGPs (Alilain et al., 
2011). Twelve weeks after spinal cord injury and peripheral nerve graft, serial 
reconstruction, retrograde viral tracers, and immunohistochemistry showed that 
serotonin fibers had regenerated from brainstem nuclei, into the graft, and further into 
spinal cord. This regeneration was accompanied by restoration of diaphragmatic function. 
More distal spinal cord injuries have revealed that serotonin fiber regeneration isn’t 
limited by proximity to the brainstem raphe nuclei (Lee et al., 2013). Following a complete 
thoracic spinal cord transection, mice were treated with a peripheral nerve graft treated 
with ChABC and a fibroblast growth factor. Six months after injury and graft, there was 
regeneration of serotonin fibers. While the majority terminated either in the graft or within 
250 µm into the lesion site, some fibers were observed as distal as 12 mm beyond the lesion 
site. Retrograde tracing showed that the majority of regenerated axons originated from 
the raphe nuclei or reticular formation. Another study has shown that the mammalian 
enzyme arylsulfatase B (ARSB) is also effective in promoting serotonin fiber regeneration 
by breaking down the inhibitory chains on CSPGs (Yoo et al., 2013). Following a spinal 
cord compression injury, treatment with either ARSB or ChABC resulted in increased 
serotonin fiber density at the compression site compared to control treatment with no 
enzyme. As with the previous studies, this was correlated with a functional recovery, as 




In some cases, peripheral nerve grafts are not necessary for serotonin fiber regeneration 
following injury, however. Following a spinal cord contusion, grafting Schwann cells that 
were engineered to secrete ChABC and a neurotrophin was shown to also be sufficient to 
increase the number of serotonin fibers in the damaged area 12 weeks after injury (Kanno 
et al., 2014). The increase in serotonin fibers is evident among the grafted cells, in the 
contused spinal cord, and in the spinal cord caudal to the injury site.  
 
In the neocortex, fixed tissue studies using immunohistochemistry against serotonin, 
which is expressed through serotonin axons, have shown that following a large dose of 
amphetamine there is massive serotonin axon degeneration followed by putative 
regeneration (Molliver et al., 1990). Amphetamine is highly neurotoxic to serotonin fibers 
and the resulting lesions showed profound serotonin fiber loss in the neocortex 2 weeks 
after the insult. Over the course of 2 to 8 months, serotonin fiber density increases in the 
neocortex. The recovery is most rapid in the frontal cortex and most delayed in the parietal 
cortex, which is indicative of the course that serotonin fibers normally run through this 
region. While highly suggestive of serotonin regeneration in the neocortex, this evidence 
remained inconclusive. Because these initial neocortical studies were performed on fixed 
tissue with serotonin antibodies, the findings could be explained by sprouting axons or 




Recently the first evidence of long-distance regeneration of serotonin axons in the central 
nervous system came in the form of in vivo two-photon time-lapse microscopy (Jin et al., 
2016). Enhanced green fluorescent expressing serotonin axons in a serotonin transporter-
EGFP BAC transgenic mouse were imaged over time in three-dimensional space before 
and for months following an amphetamine lesion. In the imaging area 70% of the axonal 
length was lost 1 week after amphetamine lesion compared to the baseline. Over 28 weeks, 
serotonin fiber density in the imaging area increased, returning to around 70% of baseline 
density. The vast majority of new axonal length that was measured had entered from 
outside of the imaging plane. While sprouting events from axons that were spared during 
amphetamine treatment did occur, they were rare, and it was even rarer for these sprouted 
axons to exit the imaging plane. It is therefore mathematically improbable that sprouting 
from outside of the imaging area could account for the profound increase in serotonin 
fiber density and highly suggestive that it is long-distance regeneration from damaged 
axons that is responsible for the new innervation. The axons that were spared in the 
amphetamine lesion were stable over time after the lesion. The same was true for 
regenerated axons; once they entered the imaging area they persisted, sometimes 
exhibiting further growth in the imaging area. The regenerated axons were 
morphologically similar to surviving axons, had distributions between fibers similar to 
fiber distributions in control animals, and exhibited the same degree of tortuosity through 
the imaging area as surviving axons and axons from control animals. Interestingly, unlike 
with regeneration in the peripheral nervous system, the regenerated axons did not follow 
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pathways left by degenerated axons (Scheib and Hoke, 2013). Furthermore, 6 months after 
amphetamine lesion the regenerated axons were competent to release serotonin as 
measured by fast-scan voltammetry experiments. These findings, taken together, show 
that serotonin fibers have the intrinsic ability to regrow in the central nervous system. 
 
However, amphetamine lesion is an unusual insult in that it does not induce a lasting 
reactive glial response (Wilson and Molliver, 1994). While the diminished regenerative 
potential of most adult neurons presents the intrinsic barrier to recovery following injury, 
reactive gliosis is a major extrinsic factor impeding regeneration (Chew et al., 2012). 
Reactive astrogliosis is initially a beneficial response. Activation of astrocytes serves to 
limit excitotoxicity through glutamate uptake, protect from oxidative stress, regulate 
inflammation, and facilitate blood-brain barrier repair (Sofroniew, 2009). With mild 
injury, or at a distance away from the main insult, this reactive response is transient and 
astrocytes return to their pre-activated state. However, with severe or prolonged insult 
this response eventually leads to harmful effects and a persisting mature glial scar. This 
glial scar serves to impede regeneration both by acting as a physical barrier as well as 
through expression of molecules that strongly inhibit regeneration (Ohtake and Li, 2015). 
The mature glial scar is also comprised of inflammatory cells, such as microglia and 
invading macrophages, which can themselves become dysregulated and further inhibit 




Regenerating serotonin fibers appear to be able to overcome these extrinsic inhibitory 
environments as well. In a spinal cord transection injury model there is evidence for 
serotonin fibers traversing across reactive astroglial bridges that span the injury site (Lee 
et al., 2010). In cortex, serotonin fibers were observed to grow further into a glial scar 
secondary to a thermal lesion than were non-serotonergic fibers (Hawthorne et al., 2011). 
Again, however, the most conclusive evidence came from two-photon in vivo time-lapse 
imaging of enhanced green fluorescent fiber expressing serotonin fibers. Following a 
penetrating stab injury through all cortical layers, which does result in a glial scarring, 
serotonin fibers were observed traversing the injury site (Jin et al., 2016). The penetrating 
stab injury completely severed all of the serotonin axons within the stab rift, with the cut 
ends of the fibers regressing no further than a few microns from the rift. Beginning at one 
week after injury, some new growth was observed from the cut end of the axons. By 
eighteen weeks post-stab, axonal length in the stab rift had returned to 80% of the baseline 
axonal length. The newly grown axons in the stab rift were also able to form new 
branchpoints within the stab rift. 
 
However, neither the amphetamine lesion nor the penetrating stab injury are the most 
clinically common injuries, so whether this regenerative capacity remains in typical 




Traumatic brain injury 
Traumatic brain injury (TBI) is a physical injury that results in the disruption of normal 
brain function. In the United States there are approximately 2.5 million emergency 
department visits involving TBI annually, a number which likely underestimates the true 
incidence (Centers for Disease Control and Prevention, 2015). TBI affects all age groups, 
but at specific risk are children (age 0-4), adolescents (age 15-19) and the elderly (age >75). 
The cause of injury across these age groups also differs. The children and elderly are at 
highest risk for TBI secondary to a fall, while adolescents are most at risk of TBI as a result 
of motor vehicle accidents (Faul and Coronado, 2015). Severity of TBI varies across the 
population as well. While children are twice as likely to be brought to an emergency 
department and diagnosed with a TBI as the elderly, the elderly are more likely to require 
hospital admission (Faul and Coronado, 2015). Across all age groups, the highest 
mortality rate is for TBI in motor vehicle accidents. Between 2007 and 2010 there was a 
large increase in emergency hospital visits for TBI while mortality from them continued 
to decrease. This is most likely due to the recent increased awareness of TBI, especially in 
the context of sports-related injuries in adolescents, while technology improvements 
continue to decrease mortality in motor vehicle accidents (Centers for Disease Control and 
Prevention, 2015). It is therefore important to note that TBI is not a discrete injury type, 
but rather a range of injury types that have diverse outcomes depending on the patient 
population and mechanism of injury. Studies on experimental animal models should 




Traumatic brain injury can be caused by a blow against or jolt of head, a penetrating injury 
to the head, or exposure to blast. TBI secondary to a blow or jolt of the head is most 
common. The severity of blows or jolts is generally based on the cause of impact. Impacts 
from sport activities tend to be milder, falls have moderate intensity impacts, and motor 
vehicle accidents have the highest likelihood of resulting in severe blows or jolts. It should 
be noted that these are only general trends; for instance, a fall from a large height has the 
potential to result in a higher energy impact than a motor vehicle accident at very low 
speeds. Likewise, not every blow or jolt, no matter how severe, results in TBI (Corrigan et 
al., 2010). Together, these injuries tend to damage tissues through biomechanical forces 
generated by rapid acceleration, deceleration, compression against the intact skull, and 
changes in intracranial pressure. Penetrating injuries cause damage through both impact 
and directl damage to brain tissue and brain vasculature. Blast injuries, which are most 
common among military personnel, are least understood, but evidence suggests that 
damage to the brain may be due to systemic effects of blasts such as disruption of lung 
tissue and subsequent hypoxia (Long et al., 2009). 
 
While the initial insult or insults resulting in TBI can be thought of as a discrete event, TBI 
itself is a chronic disease process (Masel and DeWitt, 2010). Following rehabilitation after 
injury, patients with TBI are at greater risk of death than controls, with an estimated seven 
year reduction in life expectancy (Harrison-Felix et al., 2004). Traumatic brain injury 
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patients are also at an increased risk for a wide range of morbidities, including 
neurological disorders (such as epilepsy), neurodegenerative diseases (such as 
Alzheimer’s dementia), and psychiatric disease (such as major depression) (Masel and 
DeWitt, 2010). 
 
Major depression is the most commonly reported neurobehavioral sequela of TBI (Riggio 
and Wong, 2009). While the actual prevalence of major depression following TBI is 
debated in the literature (reported values range from 27 to 61%) it is accepted that the rate 
is higher than the 17% seen in general population (Jorge et al., 2004). The causal link 
between TBI and depression remains unclear. One of the best predictors for the 
development of depression after TBI is a history of previous psychiatric illness, which 
suggests that TBI may lead to depression by exacerbating previous pathologies (Riggio 
and Wong, 2009). In terms of clinical findings, lesions to the left dorsolateral frontal cortex 
and left basal ganglia are most strongly correlated with the development of depression 
(Fedoroff et al., 1992). Traumatic brain injury may, therefore, be a result of disruption of 
executive function via the frontal-striatal-thalamic circuit. Another possibility is that 
disruption of normal monoaminergic modulation of the prefrontal cortex is responsible 
for the cognitive defects in post-TBI depressed patients. The monoamine hypothesis of 
depression states that an imbalance in monoamine, especially serotoninergic, 
neurotransmission is the biological basis of the disease. While this hypothesis is unlikely 
to explain all facets of depression, there is amble evidence to support its contributory role 
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in the pathophysiology of depression, along with involvement of the neuroendocrine 
stress axis, neuroinflammation, and neurotrophic signaling (Kohler et al., 2016). Indeed, 
the first line of treatments for depression following TBI are the selective serotonin 
reuptake inhibitors, which target the serotonergic transporter to increase serotonin 
concentration in the central nervous system (Silver et al., 2009). 
 
Given the unique capacity for serotonin fibers to regenerate in certain conditions and the 
role of the serotonergic system in neurobehavioral sequelae of TBI, the question of 
whether serotonin fibers undergo damage and are able to regenerate following TBI is of 






Chapter 2: General Methods 
 
All animal procedures were performed in compliance with National Institutes of 
Health guidelines and all protocols were approved by the Johns Hopkins School of 
Medicine Institutional Animal Care and Use Committee. 
 
Controlled cortical impact injury (CCI) protocol 
10 week old female C57BL/6 mice (Charles River) were first induced with 3% isoflurane 
anesthesia in a closed plastic container and the skull was then shaved in preparation for 
surgery. Mice were then placed in the stereotaxic device (Stoelting) with 1.5% isoflurane 
delivered via a nose cone. The skin above the skull was cleaned with alcohol and iodine 
and a midline incision was made to expose the skull. The skin was retracted medially and 
held in place with a modified Colibri retractor (Fine Science Tools). Fascia was removed 
from the skull and a round craniotomy was made with a 2.7 mm trephine drill bit (Fine 
Science Tools) using an electric drill. The craniotomy location was over the left hemisphere 
of the brain; the medial aspect of the craniotomy was against the sagittal suture and the 
antero-posterior aspect of the craniotomy was centered on the coronal suture. The skull 
over the craniotomy was carefully removed using a scalpel and tweezers, and the dura 





Figure 2. Impactors for the induction of traumatic brain injury. A) The Leica 
electromagnetic impactor used for controlled cortical impact (CCI) surgeries is pictured 
mounted to the stereotaxic device. B) A schematic of the setup used for repetitive mild 
traumatic brain injury surgeries. Panel B is reproduced from Xu et al., 2016. 
 
The electromagnetic impactor with a 1.5 mm tip (Leica) was then mounted to the 
stereotaxic device and centered over the craniotomy site at a 10 degree angle (Figure 2A). 
This angle results in the impactor being perpendicular to the brain surface under the 
craniotomy. The impactor was extended and the tip lowered until it made contact with 
the dura, as measured by the completion of an electrical circuit between the impactor and 
a wire clipped to the mouse tail. The impactor was then retracted and the impact depth 
was set to 0.75 mm past the measured surface of the dura. The electromagnetic impactor 
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was then activated resulting in an impact with a final velocity of 4 m/s and a dwell time 
of 100 ms. These parameters were chosen from a wide range of empirically tested values 
(see Table 1) to provide an injury that was consistent across animals, resulted in visible 
damage to neocortical layers 1, 2/3 and 4, and largely spared neocortical tissue anterior 
and posterior to the injury site to allow for analysis of fixed tissue in those areas. 
 
 
Table 1. Parameters of controlled cortical impact that were varied to adjust the severity 
of injury. Craniotomy diameter and impactor diameter value increments were based on 
availability of trephine drill bits and metal impactor tips. Impact depth and angle were 
set via the stereotaxic device, while impact velocity was adjusted on the electromagnetic 
impactor controller. Dwell time was kept constant at 100 ms throughout testing different 
parameter permutations. 
 
After impact the retractor was removed and the skin was closed above the craniotomy 
using 9 mm wound clips (Fine Science Tools). Mice were given subcutaneous injections 
of Baytril (2.5 mg/kg) to prevent infection and Buprenex (0.01 mg/kg) for pain 
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management. Mice were removed from the stereotaxic device and put in a recovery cage 
on their backs. Righting time, defined as the amount of seconds it took for the mice to flip 
and place all four paws on the bedding, was measured to assess the immediate injury 
severity (control: range 9-144, median 46; open skull: range 39-650, median 214; CCI: range 
36-597, median 301). Mice were then returned to group housing for the duration of the 
post-surgery time point. Open skull control mice received the same treatment, but the 
impactor was not fired. Control mice received the same treatment, but did not receive a 
craniotomy, and the impactor was not fired. Animals were sacrificed for tissue processing 
either 1 week, 1 month, or 3 months after surgery. 
 
Repetitive mild traumatic brain injury protocol 
Female C57BL/6 mice (Charles River) 8 weeks of age were anesthetized with an isoflurane, 
oxygen, nitrous oxide mixture (1:33:66, respectively). The skin above the skull was cut 
along the sagittal suture and the remaining fascia was removed. A 3.2 mm diameter, 1 
mm thick steel disc was glued onto the skull with cyanoacrylate glue. The disc was 
centered on the sagittal suture and extended to cover both the coronal and lambdoid 
sutures. The mice were removed from anesthesia and quickly placed on a foam mat (Foam 
to Size, Inc.) with the metal disc centered underneath a plexiglass tube (Figure 2B). Tape 
was used to restrain the animal. Stacked metal weights (40 g total, 10 g per section) were 
affixed to a string and elevated in the plexiglass tube to a height of 1 m above the metal 
disc. The string was then released and the weight assembly was allowed to impact the 
19 
 
metal disc. The animal was immediately moved after the initial impact to prevent a 
rebound impact. The mice were removed from the foam bed and breathing was 
monitored. If spontaneous breaths were not immediately observed, a few forced 
mechanical breaths were provided. After self-righting, the mouse was anesthetized again 
and the metal disc was removed. The skull was checked to confirm absence of fracture 
and the skin was closed with would clips (Fine Science Tools). The mice were then 
returned to group housing for the duration of the study. 
 
For mice in the 1x impact group, this procedure was performed once on day 0. For mice 
in the 4x impact group, the above procedure was repeated on day 0, day 1, day 3, and day 
7. For mice in the 8x impact group, the above procedure was repeated on the same days 
as the 4x impact group, but each animal received 2 impacts, approximately 1 hour apart. 
The metal disc was not removed in between impacts delivered on the same day. Sham 
animals underwent the same treatment but did not receive any impacts. The final day of 
impacts was treated post-surgical day 0, and all animals were sacrificed 7 days post-
surgery (i.e., 14 days after the initial impact). 
 
Tissue processing 
Mice were anesthetized with a mixture of ketamine (100 mg/kg) and xylazine (10 mg/kg) 
and perfused intracardially with ice-cold 0.01 M phosphate-buffered saline (PBS) 
followed by ice-cold 4% paraformaldehyde (PFA) in PBS. After perfusion, the brain was 
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removed and placed in 4% PFA in PBS at least overnight at 4 °C. Two days prior to slicing, 
brains were cyroprotected in 15% sucrose in PBS overnight at 4 °C followed by 30% 
sucrose in PBS overnight at 4 °C. The left hemisphere of samples was then sectioned into 
40 µm thick slices on a freezing sliding microtome. The slices were stored in PBS at 4 °C. 
 
Immunohistochemistry and image acquisition 
For the CCI experiments, tissue from all three treatment groups at each time point was 
processed together. Sections were washed with 0.3% Triton X-100 in PBS and blocked in 
5% normal goat serum and 0.3% Triton X-100 in PBS for 2 hours at room temperature. The 
sections were then incubated with primary antibody in the blocking buffer overnight at 4 
°C. The primary antibodies used were guinea pig anti-SERT (Frontier Institute #HTT-GP-
Af1400), mouse anti-NeuN (Millipore #ABN60), chicken anti-GFP (Aves Labs #GFP-1010), 
rabbit anti-GFAP (Millipore #AB5804), and rabbit anti-Iba1 (Wako #019-19741). For 
SERT/NeuN, GFAP/NeuN, and Iba1/NeuN double staining, the primary antibody 
dilutions were all 1:1000. For SERT/YFP/NeuN triple staining the dilutions were 1:1000, 
1:5000, and 1:500, respectively. Slices were washed in PBS and incubated with secondary 
antibody diluted in blocking buffer at room temperature for 2 hours. The secondary 
antibodies used were FITC-labeled goat anti-guinea pig (1:1000, Invitrogen #A18776), 
Alexa Fluor 594-labeled goat anti-mouse (1:500, Jackson ImmunoResearch Laboratories 
#115-586-062), Alexa Fluor 488-labeled goat anti-rabbit (1:500 Jackson ImmunoResearch 
Laboratories #111-546-003), Cy3-labeled goat anti-guinea pig (1:800, Jackson 
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ImmunoResearch Laboratories #106-165-003), Cy5-labeled goat anti-mouse (1:200, 
Jackson ImmunoResearch Laboratories #115-175-146) and FITC-labeled goat anti-chicken 
(1:1000, Invitrogen #A16055). The Alexa Fluor labeled secondary antibodies were 
reconstituted with water and diluted 1:1 with glycerol; all other secondary antibodies 
were reconstituted with water only. The sections were washed again and mounted on 
slides for imaging. A single photon laser scanning confocal microscope was used to 
acquire all images (Zeiss LSM 510). Imaging of tissue that was processed together was 
performed with the same settings and laser power for each sample. Experimenters were 
blinded to the treatment groups, which were interleaved throughout the imaging process. 
 
Image analysis 
Raw acquired images were exported from Zeiss LSM software in an uncompressed tagged 
image file format and stored for subsequent analysis using custom code written using the 
Anaconda Python distribution (Continuum Analytics). Imaging z-stacks were maximally 
projected and the projection was used to set a threshold for detection of pixels positive for 
SERT or Iba1 immunohistochemistry. The threshold was calculated using an iterative 
algorithm for feature extraction (Ridler and Calvard, 1978). The threshold is set to 0 to 
begin and is incrementally increased until the following condition is true (a background 
pixel is any pixel at or below threshold; an object pixel is any pixel above the current 
threshold): 
𝑡𝑡ℎ𝑟𝑟𝑟𝑟𝑟𝑟ℎ𝑜𝑜𝑜𝑜𝑜𝑜 >






After the threshold has been calculated it is applied to an image such that every 
background pixel is set to 0 (black) and every object pixel is set to 255 (the highest value 
for an 8-bit image). This serves as an unbiased systematic contrast enhancement technique 
that allows for the subsequent calculation of pixels positive for a given signal (Figure 3). 
 
 
Figure 3. Example of thresholding algorithm output applied to an image of double-
label immunohistochemistry. The left image shows a maximally projected z-stack before 
thresholding. The right side shows the same image after applying the threshold to the 
green channel. Each z-stack contained 41 images, 1 µm apart. 
 
For the quantification of serotonin fiber density, the threshold was applied to each slice of 
the z-stack before the maximal projection was created. The number of pixels above 
threshold in each individual slice was summed together and expressed as the percent of 
23 
 
pixels above threshold, where the total number of pixels was the two-dimensional 
maximally projected area. Exemplar images were generated using the same method. This 
approach was used to account for the fact that in a maximally projected image any area 
where serotonin fibers run in the z-direction would result in an underestimate of fiber 
density in the two-dimensional projection. For quantification of microglial density, a 10 
µm maximal projection was generated from the top of the imaging stack, the threshold 
was applied, and quantification was performed on the projected image. 
 
For quantification of reactive astrocytes, a manual counting method was employed on 10 
µm maximally projected images, taken from the top of the 40 µm imaging stack. All 
GFAP-positive cells that matched the distinct morphology of reactive astrocytes within 
the layer of interest were counted. In layer 1, GFAP-positive cells that were part of the pia 
mater were excluded. To confirm that manual cell counting was an accurate measure, 
counts in layer 1 were compared to the percent pixels above threshold measure and were 
found to match closely (not shown). 
 
Statistics 
Statistical significance was determined using a linear regression model followed by 
targeted t-tests adjusted for multiple comparisons. Data was divided based on imaging 
regions and the dependent variable. For each data set, an ordinary least squares regression 
model was run, fitting the data to take into account the effect of treatment group, time, 
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and the interaction between treatment group and time. If the linear model suggested an 
effect of the regressors for the group, one-tailed heteroscedastic t-tests were performed 
within a timepoint across groups and across timepoints within a group. These results of 
the t-tests were adjusted for multiple comparisons using the Bonferroni correction.  Data 
is presented as means ± the standard error of the mean. Significance throughout the text 
is denoted as follows: * indicates p < 0.05, ** indicates p < 0.01, and *** indicates p < 0.001.
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Chapter 3: Controlled Cortical Impact and 5-HT Fiber Innervation 
 
There is evidence that serotonin fibers can regenerate in the central nervous 
system, both in spinal cord (Lee et al., 2013) and neocortex (Jin et al., 2016). However, the 
neocortical injury models used in these experiments reflect unique insults. The 
amphetamine lesion does not create a glial scar (Wilson and Molliver, 1994), while the 
penetrating injury is less common clinically and leaves a relatively narrow rift to be 
crossed. Therefore, whether serotonin fibers are able to regrow following clinically 
relevant traumatic brain injury remains unknown. To address this question we analyzed 
serotonin fiber density following controlled cortical impact injury in mice. 
 
Serotonin fibers regrow following TBI 
Young adult mice (10 weeks old) were exposed to one of three treatment groups. The CCI 
group which received a craniotomy and an impact directly to the dura, the open skull 
group which received a craniotomy but no impact, and a control group that received 
neither a craniotomy nor impact. All groups received anesthesia, an incision, wound clips, 
and post-operative drugs. Mice were sacrificed at 1 week, 1 month, and 3 months post-
surgery. 
 
Double-label immunohistochemistry was performed on sagittal sections of brain 
corresponding to the middle of the craniotomy (lateral +1.32 mm) to visualize the extent 
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of serotonin fiber damage and recovery following injury. Serotonin fibers were labeled 
with an antibody against the serotonin transporter SERT, which is expressed throughout 
the axon of serotonergic cells. In order to be able to identify neocortical layers, neuronal 
cell bodies were visualized with an antibody against NeuN, which is expressed in most 
mature neuronal nuclei. 
 
Low magnification images were taken first to assess the extent of the injuries. One week 
post-surgery there was always an obvious physical deformation in the upper layers of the 
motor cortex in the CCI group (Figure 4). This damage involved layers 1, 2/3, and 4. In the 
open skull condition there was occasional damage confined to layers 1 (n = 15 out of 26) 
and 2/3 (n = 10 out of 26) underneath the craniotomy site. There was never damage to the 





Figure 4. Low magnification exemplar images of sagittal sections reveal the extent of 
injury evoked by controlled cortical impact in 2 exemplar mice per group. One week 
post-surgery the damage inflicted by controlled cortical impact is apparent (bottom row). 
The open skull group (middle row) and control groups (top row) have entirely intact 
neocortex. Occasionally damage secondary to the open craniotomy can be observed in the 
open skull condition (middle row, right side, above the lateral ventricle). 
 
Next, single-photon 40x confocal stacks were acquired to visualize serotonin fibers at 
several anatomical locations. Since serotonin fibers run in an anterior to posterior gradient 
in the neocortex (Figure 1), we wanted to observe damage and recovery both anterior 
(proximal) to the injury, where we predicted there would be relatively little damage, and 
posterior (distal) to the injury, where we predicted there would be significant fiber loss 
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due to axonal damage within the injury zone. The anterior and posterior areas were 
chosen to border either edge of the craniotomy location (anterior aspect: Bregma +1.34 
mm; posterior aspect: Bregma -1.34 mm). By choosing constant imaging areas we 
minimized between-animal variation in serotonin fiber due to the antero-posterior 
density gradient. We were also interested in whether any differences in damage and 
recovery exist among different cortical layers, for instance as a result of different serotonin 
fiber innervation patterns of the dorsal and median raphe projections (Vitalis et al., 2013). 
To this end, we imaged regions including layer 1, layer 2/3, and layer 4, both anterior and 
posterior to injury. Sections from open skull and control animals were imaged in 
corresponding regions. 
 
The SERT signal from the raw confocal stacks was contrast enhanced using an iterative 
thresholding algorithm and was maximally projected along with the raw NeuN signal to 
allow visualization and quantification of serotonin fiber density. Quantification was 
performed by summing pixels above threshold and expressing this is a percent of the total 
number of pixels in the region of interest (i.e. layer 1, 2/3, or 4 as drawn by hand, guided 
by the NeuN images). The percent pixels above threshold measure was then normalized 
to the control condition within each time point to allow comparisons between time points 




Anterior to the injury site in layer 1 there was a small decrease in serotonin fiber density 
in both the open skull (78.5 ± 8.9%, n = 9) and CCI conditions (78.6 ± 13.3%, n = 7) when 
measured one week post-surgery compared to control (100.0 ± 5.4%, n = 8) (Figure 5). 
These decreases were not statistically significant (Figure 7; t-test p > 0.0125).  
 
 
Figure 5. Exemplar images show 5-HT fiber innervation in neocortical layer 1 anterior 
to the CCI injury site, one week after surgery. Maximally projected 40x confocal z-stacks 
with thresholded SERT signal show a small decrease in serotonin fiber innervation in the 
open skull (middle) and CCI groups (right) compared to the control group (left). Damage 
due to impact can be appreciated in the CCI group by the deterioration of the NeuN 
signal. 
 
Layers 2/3 and 4 anterior to the injury site show a similar pattern of serotonin fiber loss as 
layer 1 when measured one week post-surgery (Figure 6). Neither the open skull group 
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(layer 2/3: 87.5 ± 4.5%, n = 9; layer 4: 87.4 ± 4.7%, n = 9), nor the CCI group (layer 2/3: 85.5 
± 8.2%, n = 7; layer 4: 96.0 ± 6.8%, n = 7) showed significant serotonin fiber loss compared 
to the control group (layer 2/3: 100.0 ± 2.6%, layer 4: 100.0 ± 5.5%, n = 8).  
 
 
Figure 6. Exemplar images show 5-HT fiber innervation in neocortical layers 2/3 and 4 
anterior to the CCI injury site, one week after surgery. Maximally projected 40x confocal 
z-stacks with thresholded SERT signal show little decrease in serotonin fiber density of 
layer 2/3 (top row) and layer 4 (bottom row) in the open skull (middle) and CCI groups 
(right) compared to the control group (left). 
 
Serotonin fiber density was also quantified in these areas one month and three months 
post-surgery (Figure 7). One month post-surgery serotonin fiber density was similar in 
layer 1 among all treatment groups. Serotonin fiber density was also similar between the 
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groups in layer 2/3 and layer 4. There was no appreciable increase in serotonin fiber 
density from one month to three months post-surgery in layer 1, layer 2/3, or layer 4. 
 
In summary, there were no differences in serotonin fiber density anterior to the injury site 
one week post-surgery. One month and three months after injury, serotonin fiber density 





Figure 7. Quantification of 5-HT fiber innervation anterior to the CCI injury site. 
Percent of SERT pixels above threshold was calculated to quantify serotonin fiber density. 
The data were normalized to control levels for each layer and time point. There was no 
significant fiber loss anterior to the injury site following treatment one week post-surgery 




In contrast to the region anterior to the injury site, there was a significant decrease in 
serotonin fiber density in layer 1 posterior to the injury site, when measured one week 
post-surgery (Figure 8). This decrease was present in both the open skull group (54.8 ± 
6.8%, n = 9, p < 0.001) and CCI group (45.7 ± 9.6%, n = 7, p < 0.01) compared to the control 
group (100.0 ± 6.4%, n = 8). 
 
 
Figure 8. Exemplar images show 5-HT fiber innervation in neocortical layer 1 posterior 
to the CCI injury site, one week after surgery. Maximally projected 40x confocal z-stacks 
with thresholded SERT signal show a significant serotonin fiber density decrease in both 
the open skull (middle) and CCI groups (right) compared to the control group (left). 
Serotonin fiber density in the control group posterior to the injury site is lower than 
anterior to the injury site due to the normal antero-posterior distribution of serotonin 




We also measured serotonin fiber density in deeper neocortical layers in this area (Figure 
9). In layer 2/3 posterior to the injury site there is a significant decrease in serotonin fiber 
density in the open skull group (79.7 ± 4.4%, n = 9, p < 0.016) compared to the control 
group (100.0 ± 5.9%, n = 8), but the decrease in the CCI group (79.9 ± 7.2%, n = 7) is not 
statistically significant after correction for multiple comparisons (t-test, p > 0.016). In layer 
4 there were no significant differences (p > 0.016) one week post-surgery compared to the 
control group (100.0 ± 3.6%, n = 8) for either the open skull (89.1 ± 4.3%, n = 9) or CCI (80.8 
± 7.3%, n = 7) groups despite a trend toward decreasing innervation. 
 
 
Figure 9. Exemplar images show 5-HT fiber innervation in neocortical layers 2/3 and 4 
posterior to the CCI injury site, one week after surgery. Maximally projected 40x 
confocal z-stacks with thresholded SERT signal show a decrease in serotonin fiber density 
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of layer 2/3 (top row), but no significant decreases in layer 4 (bottom row) in the open 
skull (middle) and CCI groups (right) compared to the control group (left). 
 
These results show that serotonin fibers are damaged following traumatic brain injury, 
either from an open craniotomy alone or CCI, and that serotonin fiber density is decreased 
posterior but not anterior to the injury site, consistent with their anterior-to-posterior / 
proximal-to-distal direction. Given this finding, that serotonin axon density is decreased 
in layer 1, posterior to injury, 1 week post-surgery, we sought to determine whether 
serotonin fibers are capable of regrowth following traumatic brain injury. 
 
In layer 1, posterior to the injury site, there was an increase in serotonin density for the 
open skull condition at one month (77.4 ± 8.3%, n = 8) and three months (68.7 ± 2.2%, n = 
9), but these increases were not statistically different from the density observed at one 
week post-surgery. However, there was significant recovery of serotonin fiber denisty 
observed in the CCI group (Figure 10). Density at one month (81.3 ± 8.7%, n = 6, p < 0.01) 
and three months (72.0 ± 6.1%, n = 6, p < 0.05) post-surgery were both significantly greater 
than the density observed one week post-surgery. The density for the control group did 
not change over time (one month: 100.0 ± 7.8%, n = 8; three months: 100.0 ± 5.6%, n = 8). 
 
In layer 2/3 posterior to the injury site there was no significant difference (t-test, p > 0.016) 
in innervation between groups at when measured one month post-surgery(control: 100.0 
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± 4.8%, n = 8; open skull: 85.0 ± 5.2%, n = 8; CCI: 94.5 ± 6.9%, n = 6). However, at three 
months post-surgery density for both the open skull (74.1 ± 6.5%, n = 9, p < 0.01) and CCI 
(80.7 ± 6.9%, n = 8, p < 0.05) groups were significantly lower than the control (100.0 ± 5.3%, 
n = 8) group. Density in layer 4 was not statistically different at one week post-surgery 
and this remained constant at one month (control: 100.0 ± 5.9%, n = 8; open skull: 93.2 ± 
7.1%, n = 8; CCI: 91.0 ± 3.7%, n = 6) and three months (control: 100.0 ± 4.2%, n = 8; open 







Figure 10. Quantification of 5-HT fiber innervation posterior to the CCI injury site. 
Percent of SERT pixels above threshold were calculated to quantify serotonin fiber 
innervation. The data was normalized to control levels for each layer and time point. 
There was significant serotonin fiber loss following treatment one week post-surgery. 
Significant regrowth was evident in the CCI group at one months and three months 
compared to one week. * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001. 
 
Taken together these results support the conclusion that traumatic brain injury leads to 
serotonin fiber damage in superficial layers posterior to the injury site and that, in layer 
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1, serotonin fibers are able to regrow one month and three months following a clinically 
relevant injury model (Figure 11). 
 
 
Figure 11. Exemplar images show recovery of 5-HT fiber innervation in neocortical 
layer 1, posterior to the CCI injury site. Following profound serotonin fiber loss (left; 45.7 
± 9.6%) one week post-surgery, serotonin fibers are able to re-innervate the damaged 
neocortex one month (middle; 81.3 ± 8.7%) post-surgery with fibers. This recovery persists 
at least three months post-surgery (right; 72.0 ± 6.1%). 
 
One potential confound to this interpretation is that controlled cortical impact or open 
skull injury might result in a decrease in expression of SERT posterior to the injury site, 
rather than a true loss of fibers. Under this scenario, the decrease in serotonin density 
would be an artifact of this expression change and the perceived regrowth could be 
explained by the return of SERT expression in undamaged fibers. To address this issue, 
39 
 
we repeated the controlled cortical impact protocol on serotonin transporter-Cre mice that 
received injections of the virus AAV5-EF1a-DIO-hChR2(H134R)-EYFP-WPRE-pA (Tsai, 
2009) in the dorsal raphe. This yields mice in which infected dorsal raphe serotonin 
neurons, and their neocortical axon projections, have surface membrane YFP that is 
constitutively expressed, under the control of the viral EF1a promoter rather than the 
native SERT promoter. We were then able to perform triple label immunohistochemistry 
to identify EYFP positive serotonergic axons, SERT positive serotonergic axons, and 
NeuN to identify neocortical layers. To measure fiber loss following injury, both the SERT 
and EYFP signals were processed using the iterative thresholding algorithm described 
above (Figure 12). Of the SERT positive axons, 26.9% were EYFP positive in the control. 
We found that following CCI the SERT signal was decreased to 45.5% of the control level 
and the EYFP signal was reduced to 43.2% of the control level. This strongly argues 
against the possibility that changes in SERT expression are being misinterpreted as 
serotonin fiber loss and regrowth. This finding is consistent with results from an 
amphetamine lesion experiment utilizing the same viral expression approach, which also 





Figure 12. The apparent 5-HT fiber loss following CCI is not due to decreased SERT 
expression. Mice with YFP (top) constitutively expressed in a subset of dorsal raphe 
serotonergic neurons and their projections into the neocortex exhibit a similar degree of 





Reactive gliosis is not correlated with the degree of 5-HT fiber loss 
One of the key features of the controlled cortical impact injury, especially as compared to 
an amphetamine lesion, is that it models common aspects of traumatic brain injury such 
as reactive gliosis secondary to injury. This is important as reactive gliosis is known to 
inhibit axonal growth (Yiu and He, 2006). We therefore wished to examine the scope and 
dynamics of reactive astrocytosis following controlled cortical impact and assess its 
relation to the degree of serotonin fiber loss and recovery. 
 
To achieve this sagittal sections adjacent to those used for quantification of serotonin fiber 
density were processed with double-label immunohistochemistry (Figure 13) against 
NeuN to identify neocortical layers and against GFAP, which is expressed by reactive, but 





Figure 13. Low magnification exemplar images of GFAP immunohistochemistry 
reveals the extent of reactive gliosis evoked by CCI. The extent of reactive gliosis 
following open skull treatment (middle row) and CCI treatment (bottom row) compared 
to control tissue (top row) is evident in low magnification images (left column). Focusing 
on the neocortex at slightly higher magnification reveals few reactive astrocytes in control 
tissue, but a large number of reactive astrocytes in both the open skull and CCI tissue 
(right column). 
 
In order to compare the level of reactive gliosis to the degree of serotonin fiber 
innervation, higher magnification (10x) single-photon confocal images were taken at the 
same anatomical locations as the images used for serotonin fiber density quantification. 
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The distinct morphology of the reactive astrocytes allows for accurate manual cell 
counting, which was performed for layer 1, 2/3 and 4 and expressed as cells per 100 µm2. 
 
These images (Figure 14) clearly reveal profound reactive gliosis across layers 1, 2/3, and 
4 anterior to the injury site, one week post-surgery for both the open skull (layer 1: 7.7 ± 
.3, n = 4, p < 0.001; layer 2/3: 6.3 ± 1.4, n = 4, p < 0.01; layer 4: 3.9 ± 1.3, n = 4) and CCI groups 
(layer 1: 7.5 ± 0.4, n = 4, p < 0.001; layer 2/3: 9.1 ± 0.5, n = 4, p < 0.001; layer 4: 6.3 ± 0.1, n = 
4, p < 0.001) compared to control tissue (layer 1: 1.7 ± 0.3, n = 4; layer 2/3: 0.2 ± 0.1, n = 4; 
layer 4: 0.2 ± 0.1, n = 4). This result was surprising based on the lack of significant serotonin 
fiber loss anterior to the injury site (Figure 7); we did not expect as much reactive 
astrogliosis in regions that had been spared from serotonin axon loss as in regions that 
had sustained significant serotonin fiber loss. Since the degree of reactive gliosis in layer 
1 was similar between the open skull injury and CCI groups, as was the degree of 






Figure 14. Exemplar images show reactive gliosis anterior to the CCI injury site, one 
week after surgery. Immunohistochemistry against GFAP reveals profound astrogliosis 
across all neocortical layers in both open skull (middle) and CCI (right) groups compared 
to control (left) tissue.  
 
Three months post-surgery, the number of reactive astrocytes anterior to the injury site 
decreases to near-control levels (Figure 15). In the open skull group there was a significant 
decrease in the number of reactive astrocytes in layer 1 at three months (1.9 ± 0.5, n = 4, p 
< 0.01) compared to one week post-surgery. The same trend was observed in the CCI 
group (2.8 ± 0.7, n = 4, p < 0.001). Significant decreases were also observed in layer 2/3 
(open skull: 0.7 ± 0.1, n = 4, p < 0.001; CCI: 1.9 ± 0.8, n = 4, p < 0.05) and layer 4 (open skull: 
0.3 ± 0.05, n = 4, p < 0.001; CCI: 0.8 ± 0.1, n = 4, p < 0.001) at three months compared to one 
week post-surgery. The only significant difference that remained between groups three 
months post-surgery was the number of reactive astrocytes in the CCI group (0.8 ± 0.1, n 
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= 4, p < 0.01) in layer 4 anterior to the injury site compared to the control group (0.08 ± 
0.08, n = 4). 
 
 
Figure 15. Exemplar images show reactive gliosis anterior to the CCI injury site, three 
months surgery. Immunohistochemistry reveals that three months post-surgery, 
astrogliosis across all neocortical layers in the open skull (middle) group has returned to 
control levels while some astrogliosis remains present in the CCI group (right) compared 
to control (left) tissue. 
 
Quantification of reactive astrocyte number anterior to injury one month post-surgery 
reveals that an intermediate level of astrogliosis in layer 1, while astrogliosis in layers 2/3 
and 4 has already resolved and looks similar to control levels (Figure 16). In summary, 
there is a profound amount of reactive gliosis anterior to craniotomy one week post-
46 
 
surgery, which begins to resolve at one month, and no longer significantly persists at three 
months (t-tests, p > 0.016).  
 
 
Figure 16. Quantification of reactive gliosis anterior to CCI injury site. The density of 
reactive astrocytes in both open skull and CCI groups one week following treatment is 
greatly increased. This increase is transient as there is a significant decrease in reactive 




The reactive gliosis posterior to the injury site looks similar to that anterior to the injury 
site, when measured one week post-surgery (Figure 17). Both the open skull and CCI 
groups have significant increases in reactive astrocyte density in layer 1 (open skull: 7.4 ± 
0.8, n = 4, p < 0.01; CCI: 8.1 ± 0.8, n = 4, p < 0.01) and layer 2/3 (open skull: 7.5 ± 1.7, n = 4, 
p < 0.01; CCI: 8.5 ± 1.3, n = 4, p < 0.01) compared to control levels (layer 1: 1.2 ± 0.2, n = 4; 
layer 2/3: 0.5 ± 0.2, n = 4). There is a trend toward increased reactive astrocyte gliosis in 
layer 4 as well, but due to large variability this is not statistically significant (control: 0.3 ± 
0.2, n = 4; open skull: 5.0 ± 1.6, n = 4; CCI: 5.1 ± 1.8, n = 4; t-tests, p > 0.016). 
 
 
Figure 17. Exemplar images show reactive gliosis posterior to the CCI injury site, one 
week after surgery. Immunohistochemistry against GFAP shows a stark increase in 
reactive astrocytes one week post-surgery in both the open skull (middle) and CCI (right) 




Three months following injury there is a significant decrease in reactive gliosis compared 
to one week post-surgery in the open skull and CCI groups (Figure 18). There is no change 
in the control tissue. While it appears that there is a greater degree of persistence of 
astrogliosis in the CCI group compared to the control and open skull groups at three 
months post-surgery, this difference is not statistically significant.  
 
 
Figure 18. Exemplar images show reactive gliosis posterior to CCI injury site, three 
months after surgery. Reactive gliosis has almost completely resolved in the open skull 
group (middle) which looks similar to control tissue (left) three months post-surgery. 





There are no differences between treatment groups in any measured neocortical layer at 
three months post-surgery (Figure 19). In layer 1 posterior to the injury site, reactive 
gliosis in both the open skull (1.7 ± 0.3, n = 4, p < 0.01) and CCI (3.0 ± 0.9, n = 4, p < 0.01) 
groups is significantly lower than it was at one week post-surgery. The same holds true 
for layer 2/3 (open skull: 0.4 ± 0.04, n = 4, p < 0.05; CCI: 1.4 ± 0.7, n = 4, p < 0.01).  
 
 
Figure 19. Quantification of reactive gliosis posterior to CCI injury site. There is a stark 
increase in reactive astrocyte density across all layers of neocortex when measured one 
week post-surgery in the open skull and CCI groups. The astrogliosis begins to 
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significantly resolve at one month, and there is no difference between treatment groups 
in any layer at three months post-surgery. 
 
Next we asked whether the degree of reactive gliosis was correlated with the degree of 
serotonin fiber loss following injury. To answer this, reactive gliosis and serotonin 
innervation data were combined for each animal. This yields data points that each have 
an anatomical location, treatment group, time point, reactive astrocyte density, and 
serotonin fiber density. Data points missing any of these values due to tissue processing 
were discarded from further analysis. GFAP positive cell density was then plotted against 
normalized serotonin fiber density for all treatment groups, time points, and anatomical 
locations (Figure 20A). We found that this resulted in a significant relationship between 
the reactive gliosis and serotonin fiber density using the Pearson correlation (correlation: 
-0.3895, p < 0.001). However, this correlation is trivial: it is skewed by control tissue at all 
time points, where the normalized serotonin fiber density is 100% and only rare reactive 
astrocytes are present. To a lesser degree, this correlation also reflects the fact that reactive 
gliosis resolves as serotonin fiber regrowth is observed. 
 
To more accurately address whether reactive gliosis is correlated with serotonin fiber 
damage we restricted this analysis to only include the CCI group one week post-surgery 
(Figure 20B). In this data subset there is no significant relationship (Pearson correlation, p 
> 0.05) between the two variables, a finding that reflects that even profound reactive 
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gliosis is not indicative of serotonin fiber damage.  In other words, profound reactive 
gliosis was found both anterior and posterior to the CCI injury, but only the posterior site 
showed significant loss of serotonin fibers.  Furthermore, when analysis is restricted to 






Figure 20. Scatterplots show the relationship between reactive gliosis and 5-HT fiber 
loss. A) All time points and treatment groups are plotted together and reveal a correlation 
between reactive gliosis and serotonin fiber density that is primarily a result of control 
data with high serotonin fiber density and low reactive astrocyte density. Control group 
(open circles), open skull group (gray circles), and the CCI group (black circles) are 
denoted. B) There is no significant relationship between the variables when only 
53 
 
considering the CCI group one week post-surgery. X denotes anterior regions, triangle 
denotes posterior regions. 
 
Microglial density is not correlated with the degree 5-HT fiber loss 
The response to traumatic brain injury also contains an inflammatory component. 
Microglia are an important inflammatory cell in the neocortex (Dheen et al., 2007) and 
have been shown to rapidly respond to brain injury (Davalos et al., 2005; Szalay et al., 
2016). Therefore we sought to determine whether there was a change in microglial density 
following controlled cortical impact as well as whether there was a relationship between 
microglial density and serotonin fiber loss. 
 
To visualize and quantify microglia we utilized double-label immunohistochemistry 
against Iba1, which is expressed only by microglia in the neocortex (Ito et al., 1998), and 
NeuN to identify neocortical layers on sagittal sections adjacent to those used for 
quantification of serotonin fiber density. Anatomical regions matching those used for the 
previous analysis were imaged under a 20x 0.8 N.A. objective with single-photon confocal 
microscopy. In order to capture all of the layers of interest, two dorso-ventral adjacent 10 
µm confocal stacks were captured, maximally projected, and stitched together. The Iba1 
signal was contrast enhanced using the iterative threshold algorithm described above to 
isolate microglia from background signal. Microglial density was calculated as the percent 




One week post-surgery there was no significant difference (t-tests, p > 0.016) in microglial 
density between treatment groups anterior to the injury site in layer 1 (control: 100.0 ± 
12.8%, n = 4; open skull: 88.4 ± 7.1%, n = 4; CCI: 123.1 ± 17.4%, n = 4), layer 2/3 (control: 
100.0 ± 9.9%, n = 4; open skull: 96.1 ± 4.3%, n = 4; CCI: 99.9 ± 13.1%, n = 4), or layer 4 (control: 
100.0 ± 10.9%, n = 4; open skull: 72.4 ± 3.9%, n = 4; CCI: 87.1 ± 11.7%, n = 4) (Figure 21). 
 
 
Figure 21. Exemplar images of Iba1 immunohistochemistry show microglia anterior to 
the CCI injury site, one week after surgery. There does not appear to be an increase in 
microglial density one week post-surgery in neocortical layers 1, 2/3, or 4 in open skull 




Microglial density remained constant anterior to the injury site throughout the 
experimental time points (Figure 22). While a there is a trend toward increased microglial 
density in layer 1 compared to control density at one week, one month, and three months 
post-surgery, there were no statistical differences in the groups, likely a result of high 
variability of microglia visible between samples. Microglia activation secondary to injury 
leads to morphological changes including increased soma size and shortened processes 
(Cho et al., 2006). Analysis to determine whether these shape changes are present anterior 





Figure 22. Quantification of microglial density anterior to the CCI injury site. There are 
no differences in microglia density between control, open skull, and CCI treatments at any 
of the time points measured. 
 
As with the anterior to injury region, there were no microglia density differences between 
treatment groups posterior to the injury site one week post-surgery (Figure 23). Microglia 
density for the open skull (layer 1: 92.5 ± 14.2%, n = 4; layer 2/3: 89.7 ± 4.7%, n = 4; layer 4: 
92.8 ± 4.5%, n = 4) and CCI (layer 1: 111.4 ± 24.6%, n = 4; layer 2/3: 103.4 ± 8.3%, n = 4; layer 
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4: 94.5 ± 7.1%, n = 4) groups was comparable to control levels (layer 1: 100.0 ± 16.0, n = 4; 
layer 2/3: 100.0 ± 11.0%, n = 4; layer 4: 100.0 ± 11.3%, n = 4) in layers 1, 2/3, and 4. 
 
 
Figure 23. Exemplar images of Iba1 immunohistochemistry show microglia posterior to 
CCI injury site, one week after surgery. There are no significant differences in microglia 
density one week post-surgery posterior to injury in neocortical layers 1, 2/3, or 4. 
 
When we quantified microglial density posterior to the injury site at later time points (one 
month and three months post-surgery) we also did not observe any significant changes 





Figure 24. Quantification of microglial density posterior to CCI injury site. There were 
no significant differences in microglial density posterior to the injury site observed in 
layers 1, 2/3, or 4 among the treatment groups for any of the observed experimental time 
points. 
 
Finally we asked if, even though there were no clear increases in microglial density 
following injury, there was a relationship between serotonin fiber loss and microglial 
density. This could suggest that either serotonin fiber damage, or related processes, attract 
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microglia to the damaged area or that an increase in microglia and related inflammatory 
processes could lead to exacerbation of serotonin fiber damage. 
 
The same approach used to analyze the relationship between reactive astrogliosis and 
serotonin fiber density was used. When visualizing data for all of the treatment groups 
and experimental time points together, we did not observe a correlation between 
microglial density and serotonin fiber density (Figure 25A). This was in contrast to a 
significant relationship seen at this level between reactive gliosis and serotonin fiber 
density. This is because while there are very few reactive astrocytes in control tissue, or 
injured tissue at late time points, microglia are always present, both in healthy and injured 
tissue. 
 
To see if controlled cortical impact injury affected microglial density, we looked only at 
the subset of data from the CCI group one-week post injury (Figure 25B). There was no 
significant relationship (Pearson correlation, p > 0.05) between microglial density and 





Figure 25. Scatterplots show the relationship between microglial density and 5-HT 
fiber loss. A) Plotting microglial density against serotonin fiber density for all treatment 
groups and time points does not reveal a relationship between the two measures. Control 
group (open circles), open skull group (gray circles), and CCI group (black circles) are 
denoted. B) There is also no significant relationship between the variables when only 
considering the CCI group one week post-surgery. X denotes anterior regions, triangle 





Traumatic brain injury, either from an open craniotomy alone or CCI, leads to significant 
serotonin fiber loss posterior to the impact region while sparing axons anterior to the 
impact region as observed one week post-surgery. This effect is greatest in layer 1 of the 
neocortex. This apparent fiber loss in not an artifact of reduced SERT expression as 
indicated by experiments using YFP expressed in SERT-positive neurons under the 
control of a constitutively-active viral promoter. Regrowth of serotonin fibers is observed 
at one month and three months post-surgery posterior to the impact region. There is 
profound reactive gliosis present one week post-surgery that begins to resolve at one 
month and returns to control levels three months post-surgery. However, the degree of 
reactive gliosis is not correlated with the degree of serotonin fiber loss in the CCI group. 
Microglial density does not appear to change in response to open skull or CCI injuries, 




Chapter 4: Repetitive Mild Traumatic Brain Injury and 5-HT Fiber 
Innervation 
 
In recent years there has been growing evidence that repetitive mild traumatic 
brain injury (rmTBI), such as repeated concussions sustained during sports activity, can 
lead to emotional, physical, and cognitive defects months and years after injury, 
collectively termed post-concussive syndrome (Williams et al., 2010). The emotional 
features of post-concussive syndrome include irritability, anxiety, and depression, which 
could be a clinical manifestation of damage to serotonergic innervation of the neocortex 
(as well as other brain regions). To test this possibility we exposed mice to an rmTBI model 
and quantified serotonin fiber density in multiple regions of neocortex. This work was 
done in collaboration with Drs. Leyan Xu and Vasillis Koliastsos. 
 
rmTBI does not lead to decreased 5-HT fiber innervation in neocortex 
Mice were exposed to a closed-skull, non-contusive, impact acceleration injury that 
mimics the biomechanics of concussion inducing impacts (Xu et al., 2016). We began with 
a pilot study to assess whether there is a graded effect of the injury, with mice receiving 
either no impacts (sham group), a single impact (1x group), one impact per day on four 
days spaced over a week (4x group), or two impacts a day spaced over a week (8x group). 
Animals with visible fractures of the skull following any of the hits were sacrificed 
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immediately and excluded from analysis. Note that sham group in these experiments 
therefore receives no treatment as this model does not utilize a craniotomy, unlike the 
open skull condition in the controlled cortical impact model. Mice were allowed to recover 
for one week after the last day of impacts and were then sacrificed. 
 
Double-label immunohistochemistry against SERT to visualize serotonin fibers and NeuN 
to identify neocortical layers was performed on sagittal sections of the left hemisphere 
(Lateral 0.60 mm; chosen to be near the midline, but before the cortex begins curving 
toward the medial longitudinal fissure). Because the biomechanics of the injury can lead 
to dissimilar forces on different anatomical areas, we imaged both motor and 
somatosensory cortex using single-photon microscopy. The imaging z-stacks were 
maximally projected and the SERT signal was contrast enhanced using an iterative 
thresholding algorithm. Serotonin fiber density was measured as the percent of all pixels 
in the neocortical layer of interest that were positive for thresholded SERT signal.  
 
In layer 1 of motor cortex there was no significant difference (t-tests, p > 0.0125) in 
serotonin fiber density between the sham (18.0 ± 3.2%, n = 3), 1x impact (21.0 ± 6.4%, n = 
3), 4x impact (19.8 ± 3.9%, n = 4), and 8x impact (22.0 ± 4.0%, n = 2) groups (Figure 26). In 
addition, there was no gross anatomical distortion of the tissue or evidence of necrosis 
based on the fact that NeuN positive neuronal cell bodies have well defined borders in all 





Figure 26. Exemplar images show 5-HT fiber innervation in motor cortex following 
repetitive mild TBI. Serotonin fiber density appears similar one week after impacts in the 
1x impact, 4x impact, and 8x impact groups compared to tissue from sham treated control 
animals. 
 
We also quantified serotonin fiber density in layers 2/3 and 4 in motor cortex, but did not 




Figure 27. Quantification of 5-HT fibers in motor cortex from a repetitive mild TBI 
(rmTBI) pilot study. There were no differences in serotonin fiber density following rmTBI 
across a range of injury severity. Layer 1 had a greater density of serotonin fibers than 
deeper cortical layers, which reflects the normal serotonin fiber innervation pattern in 
adult mouse neocortex. Sample size is as follows: sham n = 3, 1x n = 4, 4x n = 4, 8x n = 2. 
 
It is possible that fibers in motor cortex were spared because they were anterior to the area 
above which the impact was made. We therefore also measured serotonin fiber density in 
the somatosensory cortex which lies directly underneath the area of the skull that was 
impacted. However, we still did not observe differences in serotonin fiber innervation in 
layer 1 among the treatment groups (sham: 12.6 ± 4.5%, n = 3; 1x: 16.9 ± 2.1%, n = 3; 4x: 12.7 
± 4.5%, n = 4; 8x: 15.2 ± 0.5%, n = 2) (Figure 28). As in the motor cortex, there was no 





Figure 28. Exemplar images show 5-HT fiber innervation in somatosensory cortex 
following repetitive mild TBI. Serotonin fiber density in layer 1 of the sham-treated 
somatosensory cortex is lower than in the sham-treated motor cortex due to the normal 
antero-posterior distribution of serotonin fibers. However, there is no difference in 
serotonin fiber density between the treatment groups in layer 1 of somatosensory cortex. 
 
We also measured the serotonin fiber density in layers 2/3 and 4 of somatosensory cortex, 





Figure 29. Quantification of 5-HT fibers in somatosensory cortex from a repetitive mild 
TBI (rmTBI) pilot study. There were no differences in serotonin fiber density between 
treatment groups in the somatosensory cortex. Innervation was quantified in layer 1, 2/3, 
and 4. Sample size is as follows: sham n = 3, 1x n = 4, 4x n = 4, 8x n = 2. 
 
While there was no evidence of rmTBI leading to serotonin fiber loss in the pilot data, the 
possibility remained that we were missing an effect due to small sample size. We therefore 
repeated the experiment (sham and 8x impact groups, only) on a larger population of 
mice. Data from the pilot experiment was normalized to the average innervation density 
of the sham group for each region. Data from the additional experiment was normalized 
the same way using internal sham control images that were processed together. The 
normalized data sets were then combined and averaged. There was no difference 
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observed between sham (n = 9) and 8x impact (n = 7) groups in layers 1, 2/3, or 4 in either 
motor or somatosensory cortex (Figure 30). 
 
 
Figure 30. Quantification of 5-HT fiber innervation in motor and somatosensory cortex 
following repetitive mild TBI. Expanding the sample size of the sham and 8x impact 
groups did not reveal an effect of repetitive mild traumatic brain injury on serotonin fiber 
density in either motor or somatosensory cortex, in any of the neocortical layers analyzed. 
Sample size is as follows: sham n = 9, 8x n = 7. 
 
rmTBI does lead to reactive gliosis in the optic tract 
Another possibility is that, for an unidentified reason, the impact surgeries were 
unsuccessful and did not produce the type of force expected for this model. This rmTBI 
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model has been found to produce diffuse axonal damage and neuroinflammation in the 
optic tract under the same conditions as the present study (Xu et al., 2016). Therefore we 
turned to the optic tract to determine whether the injuries were similar to those previously 
reported. 
 
Immunohistochemistry against GFAP to identify reactive astrocytes was performed and 
the optic tract of sham treated and 8x impact tissue was imaged using single-photon 
confocal microscopy. Sagittal slices from a single sham and 8x animal were used. The 
lateral plane of the sagittal slices was matched to that used for serotonin fiber density 
imaging. The confocal z-stacks were maximally projected and the GFAP signal was 
contrast enhanced using an iterative thresholding algorithm. We observed an obvious 
subjective increase in reactive astrocytes in the optic tract of tissue from the 8x impact 
group compared to tissue from sham treated animals (Figure 31). This confirmed that the 
impact injuries were performed successfully and produced effects in line with 






Figure 31. Exemplar images show reactive gliosis in the optic tract following repetitive 
mild TBI. Immunohistochemistry against GFAP reveals an increase in reactive astrocytes 
in the optic tract of tissue from the 8x impact group (bottom right) compared to tissue 
from the sham treated group (bottom left). A low magnification mosaic image (top) shows 
the location of confocal imaging (white box).  
 
Conclusion 
We hypothesized that repetitive mild traumatic brain injury would result in graded 
damage to neocortical serotonin fibers as the number of impacts was increased. However, 
we did not observe a difference in serotonin fiber density between control sham-treated 
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animals and any of the impact conditions. We confirmed that this was not do to a failure 
of the impacts to elicit injury as we replicated the reactive gliosis in the optic tract in the 




Chapter 5: General Discussion 
 
The purpose of these studies was to investigate whether there is a loss of serotonin 
fibers in mouse neocortex following traumatic brain injury, and if so, whether serotonin 
fibers are able to regrow to innervate the injured tissue. We found that following traumatic 
brain injury, either from CCI or an open skull injury, serotonin fiber density is decreased 
posterior (distal; Figures 8 and 10) but not anterior (proximal; Figures 5 and 7) to the 
impact when measured in layer 1 at one week post-surgery, and serotonin fibers are 
capable of regrowing into the injured area by one month post-surgery (Figure 11). 
Traumatic brain injury in this model was associated with significant reactive gliosis both 
anterior (Figures 14-16) and posterior (Figures 17-19) to the impact, but the level of 
reactive gliosis was not correlated with serotonin fiber density when measured 1 week 
after injury (Figure 20). Microglia are involved in the neuroinflammatory response to 
injury but there was no increase in density of these cells in injured or surrounding areas 
(Figures 21-24). We failed to see serotonin fiber loss in an established repetitive mild 
traumatic brain injury model (Figures 26-30; Xu et al., 2016), despite observing hallmarks 
of injury in the optic tract (Figure 31). 
 
Limitations of the experimental models 
The controlled cortical impact model of traumatic brain injury is highly reproducible, but 
one major disadvantage is the reliance of the model on a craniotomy over the impact site. 
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In the present study the craniotomy was left open, covered only by skin closed with a 
wound clip, before mice were returned to group housing. Under these conditions there 
was an unexpectedly large reactive gliosis response (Figure 17) as well as an unexpectedly 
large amount of serotonin fiber loss (Figure 8) in the open skull group compared to control 
animals that did not receive a craniotomy. There are several potential mechanisms by 
which serotonin fibers could have been damaged in this group. One likely explanation is 
that normal behavior such as social grooming or scratching at the wound site could result 
in damage to the tissue. While there was generally no gross deformity to the brain tissue 
under the craniotomy in these animals (Figure 4), this does not preclude a lighter insult 
from having selectively damaged certain fibers or structures in the area. Another 
possibility is that temperature dysregulation as a result of the craniotomy, which can 
lower brain temperature as much as 10 °C below core body temperature, either directly 
or indirectly leads to damage of serotonin fibers (Kalmbach and Waters, 2012). Regardless 
of the precise mechanism, however, this finding reinforces the importance of considering 
the craniotomy itself as an aspect of the injury when interpreting results from controlled 
cortical impact experiments. 
 
Another surprising finding was the lack of serotonin fiber loss in deeper neocortical layers 
posterior to the impact site (Figure 10). Despite a reactive gliosis response in layers 1, 2/3, 
and 4, there was only significant fiber loss after controlled cortical impact in layer 1. The 
most straightforward explanation relies on the fact that deeper neocortical layers are 
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innervated by projections from the dorsal raphe, the fibers of which course anterior to 
posterior in deeper cortical layers with branches extending to innervate layers 2/3 and 4. 
These fibers could have been spared the full force of the controlled cortical impact while 
fibers from the median raphe which preferentially course in and innervate layer 1 were 
transected (or at least strongly compressed) by the impact, resulting in the observed 
decrease there. 
 
While there was significant regrowth of serotonin fibers from one week post-surgery to 
one month post-surgery, there was not a further significant increase in serotonin fiber 
density between one month and three months post-surgery (Figure 11). There are two 
non-mutually exclusive explanations. The first is that there is a physiological limit to the 
amount of regrowth that serotonin fibers are capable of after injury and that this limit is 
reached by or soon after the one month time point. The second is that the plateau in 
regrowth between one month and three months reflects a dynamic equilibrium between 
two effects: serotonin fiber regrowth and progressive atrophy of surviving or new 
serotonin fibers. It has been shown that traumatic brain injury is a progressive 
degenerative process, with neuronal death persisting at least one year following a 
traumatic brain injury in rat (Smith et al., 1997). Therefore it is possible that secondary 





It was recently reported that SERT expression decreases 7 days after controlled cortical 
impact injury in mice as measured by mRNA expression via real-time PCR and protein 
levels via western blotting (Abe et al., 2016). The authors also noted that, while not 
significant, there seemed to be a rebound in SERT expression 14 days post-surgery. Based 
on this data they concluded that damaged serotonin fibers decreased expression of SERT, 
but that this damage was not irreversible. Our current data suggest that this interpretation 
is incomplete. We confirm that SERT expression is decreased following controlled cortical 
impact, but also show that this is in fact due to serotonin fiber degeneration as measured 
by loss of serotonin fibers labeled with YFP that is not dependent on SERT expression 
(Figure 12). The increase in SERT expression described by the authors at 14 days post-
surgery, then, could in fact be early regrowth of serotonin fibers into the injured area. 
 
We had hypothesized that repetitive mild traumatic brain injury would also result in 
damage to serotonin fibers. However, we did not see a decrease in serotonin fiber 
innervation using our methodology across a range of repetitive mild traumatic brain 
injury severity (Figures 27 and 29). This negative finding is not a result of these injuries 
being too mild. The strength of the impact can be appreciated by the need to manually 
resuscitate mice following injury. Repeated impacts lead to diffuse axonal damage in 
certain white matter tracts, degeneration of axons in the optic nerve and tract, and a 
neuroinflammatory response evidenced by microglia activation and reactive astrogliosis 
(Xu et al., 2016). Consistent with these published findings, we also observed reactive 
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astrogliosis in the optic tract (Figure 31). Our findings should not be taken as conclusive 
evidence against serotonin fiber damage as a result of repetitive mild traumatic brain 
injury, however. It is possible that there exist functional deficits in the serotonergic system 
as a result of injuries from this model that are not reflected in a serotonin fiber density 
measure. It is also possible that while this model does not produce damage to serotonin 
fibers, other models of mild traumatic brain injury may reveal that this causal link does 
exist under some conditions. 
 
Implications for human traumatic brain injury 
One of the issues facing clinical treatment of traumatic brain injury is that promising 
preclinical studies have failed at the clinical trial stage (Xiong et al., 2013). This is a 
consequence of the heterogeneity of traumatic brain injuries that present in the clinic. 
Therapies that are developed and found to be successful in one animal model may not be 
effective in other animal models or across diverse injuries in the clinic. Our findings of 
serotonin fiber loss in one traumatic brain injury model but not another help highlight this 
issue. We need to continue to develop models that complement each other and the use of 
multiple models moving forward will be important. Different impact models may yield 
different results, but by using the strengths of individual models and not overgeneralizing 
between models, this should serve to advance our understanding of the mechanisms 




Controlled cortical impact (CCI) creates a reproducible injury that is pathologically 
similar to human traumatic brain injury (TBI) across a range of insult strength. Mild 
severity injuries lead to axonal damage in the subcortical white matter, while moderate 
severity injuries induce extensive damage to both cortical and subcortical fibers (Fox et 
al., 1998). Both mild and moderate injuries lead to long-lasting fine motor coordination 
deficits. Severe CCI can lead to prolonged (up to 36 hour) coma with axonal injury visible 
in subcortical white matter, the thalamus, and the midbrain (Lighthall et al., 1990). In line 
with differences in axonal damage, the severity of TBI dictates the degree of behavioral 
deficits (Yu et al., 2009). CCI injury is also accompanied by degeneration of neurons in 
cortex adjacent to site of injury, as well as the ipsilateral hippocampus and dentate gyrus 
(Smith et al., 1995). There is also evidence from acute slice recordings that loss of inhibitory 
interneurons in the cortex following CCI results in increased cortical excitability and 
glutamatergic signaling (Cantu et al., 2015). Data on damage to specific axonal fiber types 
following controlled cortical impact is lacking. 
 
The fact that serotonin fibers are damaged by controlled cortical impact or the open skull 
treatment, and that serotonin fibers are able to reinnervate injured areas provides an 
important insight into the potential biological basis behind certain outcomes secondary to 
traumatic brain injury, such as depression. Loss of serotonin fibers reinforces the 
importance of treating traumatic brain injury as a disease process rather than a distinct 
injury event; even if the immediate effects of an injury resolve, there is the potential for 
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continued dysfunction of a major neuromodulatory system in the neocortex. This new 
evidence also serves as an important target for potential therapies that either serve to 
decrease serotonin fiber loss following injury or aid in increasing the rate or degree of 
reinnervation in injured areas. 
 
Future directions 
While we now know that serotonin fibers regenerate following traumatic brain injury, 
there are many questions that these results raise. One is whether serotonin fibers are truly 
unique in their ability to regenerate following injury. A hypothesis to explain why 
serotonin fibers are able to regenerate in the neocortex is that the majority of release sites 
do not have a post-synaptic partner (they utilize volume transmission instead; Beaudet 
and Descarries, 1978), and therefore regeneration to the same general area may be 
sufficient to restore function. It is therefore possible that other neuromodulatory systems 
that do not need to form specific synaptic contacts to exert their influence also retain the 
ability to regrow in the mature brain. Candidates for this include acetylcholine, dopamine, 
histamine, and norepinephrine fibers. 
 
Another question raised by the results of the present study is how the serotonin fibers are 
regrowing. While it has been shown that serotonin fibers can regrow into injured areas 
both via long distance regeneration and via local sprouting we don’t know which 
dominates here and these processes are indistinguishable in fixed-tissue imaging with 
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between animal comparisons. Following a penetrating stab injury, in vivo imaging 
revealed that the transected serotonin fibers retract from the stab rift minimally and 
regrowth occurs from the severed ends into the injured area (Jin et al., 2016). This 
regeneration is able to regrow through the stab rift despite the presence of a glial scar. 
Recovery following controlled cortical impact may mirror recovery following a 
penetrating stab injury. However, because reactive gliosis is much more profound 
following controlled cortical impact, it is possible that regenerating serotonin fibers are 
unable to penetrate deep enough into the damaged area and that local sprouting from 
surviving serotonin accounts for the majority of regrowth.  In vivo two-photon time-lapse 
imaging of serotonin fibers following traumatic brain injury would provide the necessary 
data to address this by allowing for quantification of the rate of local sprouting and 
visualization of how fibers enter and spread through the injured area. 
 
Similarly, we don’t know if all serotonin neurons have the same capacity to regenerate. 
Results from two-photo in vivo imaging of serotonin fiber regeneration following 
amphetamine lesion showed that serotonin fibers do not regrow in the exact same 
locations as fibers used to be, suggesting that the original innervation pattern does not 
need to be replicated for functional recovery (Jin et al., 2016). For instance, if controlled 
cortical impact leads primarily to the damage of fibers in layer 1 posterior to injury, which 
originate from the median raphe, do the regrowing fibers originate from same neuronal 
population, or is layer 1 reinnervated by fibers from the relatively spared dorsal raphe 
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pathway? Developmentally, all of the dorsal raphe neurons originate from rhombomere 
1, while the median raphe contains neurons originating from rhombomeres 1, 2, and 3 
(Jensen et al., 2008). It has been recently shown that serotonin neurons have rhombomere 
lineage-specific gene expression patterns (Okaty et al., 2015). These gene expression 
patterns are likely to confer subtype-specific functions, which could involve aspects of 
intrinsic regenerative capacity. Labeling of different serotonin neuron populations would 
help pinpoint which fibers are most susceptible to damage and which are able to regrow. 
This would approach could be used to complement the in vivo two-photon imaging 
experiments suggested above.  
 
Could changing the activity of the serotonin system alter serotonin fiber loss following 
traumatic brain injury or effect regrowth? There is evidence that selective serotonin 
reuptake inhibitors (SSRIs) expand the recovery window for motor function following 
stroke in a mouse model by reducing inhibitory interneuron number in premotor cortex 
(Ng et al., 2015). This finding suggests the serotonin system may itself play a role in 
mitigating the extent of secondary damage as a result of stroke, and perhaps also 
traumatic brain injury. It would be interesting, therefore, to see if administration of SSRIs 
or other serotonin receptor agonists and antagonists could reduce the amount of serotonin 
fiber loss seen in traumatic brain injury models, or increase the rate or extent of recovery 
of serotonin fibers. It should be noted, however, that traumatic brain injury leads to a 
decrease of SERT as well as other serotonin receptors such as 5-HT2A, which are the precise 
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targets of these proposed treatments (Dam et al., 2007). Treatment timing, therefore, may 
be critical in revealing an effect. 
 
Lastly, it will be important to confirm that fibers that regrow following traumatic brain 
injury are functional. While technically difficult, it is possible to measure serotonin release 
in mouse neocortex using fast-scan cyclic voltammetry (Wood and Hashemi, 2013). This 
approach was successfully utilized to show that serotonin fibers which regenerated 




The studies presented in this dissertation show that serotonin fibers are susceptible to 
damage from traumatic brain injury, and importantly, that they are able to regrow 
following this type of insult. This is a big step forward in our understanding of traumatic 
brain injury as it questions the dogma that there is no significant repair following injury 
in the mature adult brain. By combining behavioral, biomechanical, biochemical, and 
physiological data from multiple traumatic brain injury models we can ultimately 
understand the impact of traumatic brain injury on the serotonin system and help reduce 
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